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Background: Demographic and practice modality changes during the past decade have led to a substantial shift in the
management of peripheral vascular disease. This study examined the effect of these changes using large national and
regional data sets on procedure type, indications, morbidity, and on the primary target outcome: limb salvage.
Methods: National Inpatient Sample (NIS) data sets and New York (NY) State inpatient hospitalizations and outpatient
surgeries discharge databases from 1998 through 2007 were used to identify hospitalizations for lower extremity
revascularization (LER) and major amputations. Patients were selected by cross-referencing diagnostic and procedural
codes. Proportions were analyzed by 2 analysis, continuous variables by t test, and trends by the Poisson regression.
Results:The national per capita (100,000 population, age>40 years) volume ofmajor amputations decreased by 38%. The
volume for national and regional use of endovascular LER doubled. The volume of open LER decreased by 67% from
1998 through 2007. Ambulatory endovascular LER grew in NY State from 7 per capita in 1998 to 22 in 2007.
Interventions declined by 20% (93 to 75) for critical limb ischemia (CLI) but increased by nearly 50% for claudication.
Outpatient data analysis revealed a fivefold increase in vascular interventions for CLI and claudication. Nationally,
endovascular LER interventions quadrupled (8% to 32%) for CLI and doubled (26% to 61%) for claudication. A parallel
reduction occurred inmajor amputations for patients with CLI (42% to 30%), for other PAD diagnoses (18% to 14%), and
for claudication (0.9% to 0.3%). Although surgical interventions for CLI declined significantly for octogenarians from
317 to 240, outpatient interventions increased for CLI, claudication, and other diagnoses in all age groups. Comorbidi-
ties for patients treated in 2006 were substantially greater than those of a decade ago. For most procedures, cardiac and
bleeding complications have significantly decreased during the last decade. Length of stay (LOS) declined from 9.5 to 7.6
days and the percentage of short (1-2 day) hospitalizations increased from 16% to 35%.
Conclusion: Although patients today, whether treated for claudication or CLI, have more comorbidities, the rates of
amputation, the procedural morbidity and mortality, and LOS have all significantly decreased. Other variables, including
changes in medical management and wound care, undoubtedly are important, but this change appears to be largely due
to the widespread and successful use of endovascular LER or to earlier intervention, or both, driven by the safety of these
techniques. ( J Vasc Surg 2010;51:878-85.)Peripheral arterial disease (PAD) affects 8 to 12 million
Americans, carries an increased risk of cardiac morbidity
and mortality, and leads to a depressed quality of life and
possible limb loss.1,2 Given the evolving demographics and
the increasing prevalence of PAD with age in the United
States, there has been an enhanced focus on developing safe
and effective treatment.
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878Practice modality changes during the past decade have
led to a substantial shift in the clinical management of
vascular disease. Previous reports analyzing data primarily
for the 1990s suggested that endovascular therapies could
reduce morbidity, mortality, lengths of stay (LOS), and
limb loss.3-5
In this study, we examine the more recent effect of this
practice evolution, using large national and corroborative
regional data sets on limb salvage, mortality, complications,
and resource utilizations. Has the safety of vascular proce-
dures improved? And if it has, who has benefitted?
METHODS
Data source and patient population. The National
Inpatient Sample (NIS) data sets and New York (NY) State
inpatient hospitalizations and outpatient surgeries dis-
charge databases from 1998 through 2007 were used to
identify hospitalizations with lower extremity revasculariza-
tion (LER) and major amputations.
The NIS, part of the Healthcare Cost and Utilization
Project (HCUP), is an annual database of hospital inpatient
stays that is used by researchers and policy makers to
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utilization, access, charges, quality, and outcomes. TheNIS
is the largest all-payer inpatient care database in the United
States. It contains data from approximately 8 million hos-
pital stays each year. The 2007 data fromNIS, derived from
40 states, comprises about 90% of all hospital discharges in
the United States. The NIS represents approximately 20%
of U.S. community hospitals, defined by the American
Hospital Association as “all non federal, short term, gen-
eral, and other specialty hospitals, excluding hospital units
of institutions.” For our analysis, we used the Inpatient
Core File, which contains data for 100% of the discharges
from a sample of hospitals in participating states.
The NY hospital discharge and ambulatory surgery
data were obtained from NY State Health Department’s
Statewide Planning and Research Cooperative System
(SPARCS). These data sets followed the Uniform Hospital
Minimum Discharge Data Survey’s recommendations and
include principle and multiple secondary diagnoses, princi-
ple and secondary procedures (International Classification
of Diseases, Ninth Revision, Clinical Modification), age,
gender, race, hospital identification, principle payer, LOS,
and, disposition among others.
The NIS provides statistically derived national esti-
mates, whereas the state-based data sets are a census of all
discharges. The large sample size of NIS (about 8 million
discharges per year) allows subgroup analyses with a certain
degree of accuracy and reliability. The National Ambula-
tory Surgery Survey data were not available for 1999-2005.
Because national estimates of the trend in ambulatory
surgery for PAD cannot be assessed, we used NY State data
to evaluate this patient subset.
Patient population. Treatment groups were identi-
fied by matching all relevant procedure codes with diagnos-
tic codes (Table I, online only). The following treatment
groups were analyzed: open LER, endovascular LER (endo
LER), and major lower limb amputations. The diagnosis
and procedure code groupings and linkages were selected
based on experience from prior studies6 and a survey of
practitioners to ascertain which codes weremost commonly
used clinically. Patients with diagnosis codes of atheroscle-
rosis with rest pain (440.22), ulceration (440.23), or gan-
grene (440.24) were included in the critical limb ischemia
(CLI) group. Patients with diagnoses code 440.21 were
included in the claudication group. Patients who did not
have CLI or claudication, but had vascular intervention,
were included in other PAD diagnoses group that encom-
passed lower extremity (LE) embolism, thrombosis, aneu-
rysms, and osteomyelitis. Only hospitalizations for patients
aged 40 years were included in the analysis.
We assessed the comorbidities (primary and all second-
ary diagnoses) of diabetes mellitus, hypertension, chronic
obstructive pulmonary disease (COPD), coronary artery
disease (CAD), renal disease, cerebrovascular disease, and
disorders of lipid metabolism. Complications (primary and
all secondary diagnoses) included cardiac events, stroke,
respiratory complications, bleeding, and infection.6Statistics. Results were expressed as the rate of the
variable per 100,000 population of the specified age group
and the rate of procedures per 100 hospitalizations with
claudication, critical ischemia diagnoses, or other vascular
diagnoses. For the per capita calculations, annual nation-
wide and state census information was obtained from the
Centers for Disease Control and Prevention Wonder tool.7
Univariate analyses were conducted by using t tests for
continuous variables and the 2 test for dichotomous vari-
ables. We used the Wald 2 statistic for regional or the
Rao-Scott F adjusted 2 statistic for NIS national estimates.
Poisson regression analysis was used to analyze trends in per
capita hospitalizations, and the 2 test was used for trends
to analyze mortality and amputation trends. Statistical sig-
nificance was expressed as P values and 95% confidence
intervals (CIs), with values of P  .05 considered signifi-
cant. Data sets were analyzed with SAS 9.1 software (SAS
Institute, Cary, NC).
RESULTS
The rate of surgical hospitalizations for patients with
LE peripheral arterial diseases (PAD) per 100,000 popula-
tion aged40 years slightly decreased during study period
from 192 hospitalizations (95% CI, 177-220) in 1998 to
183 (95% CI, 162-204) in 2007. However, substantial
changes were observed in the type of treatment (Fig 1, A).
Open revascularizations decreased from 111 (95% CI, 98-
124) to 68 (95% CI, 60-77) per 100,000 population, while
revascularizations with endovascular approach almost dou-
bled, from 45 (95% CI, 38-51) in 1998 to 94 (95% CI,
81-107) in 2007. At the same time, the number of major
amputations declined by 38% from 59 (95% CI, 54-65) in
1998 to 37 (95% CI, 33-41) per 100,000 population in
2007. These trends were all statistically significant (P 
.0001). Over time, 8.5% of hospitalizations included major
amputations and revascularization or open and endovascu-
lar procedures. National trends were confirmed by data
from NY State. In addition, ambulatory endo LER proce-
dures grew from 7/100,000 in 1998 to 22/100,000 in
2007 (Fig 1, B).
Although most procedures were performed for CLI,
we observed a 20% decline in this group from 93/100,000
in 1998 to 75/100,000 population in 2007 nationally (Fig
2, A). The rate of hospitalizations with other PAD diag-
noses that required surgical intervention also decreased
slightly, from 78/100,000 in 1998 to 70/100,000 popu-
lation in 2007 (Fig 2). However, substantial changes were
observed among patients with claudication. After a stable
rate of treatment in 1998 to 2002, interventions increased
by almost 50% from 2003 to 2007. We also observed
striking changes in outpatient treatment in NY State: it
increased by 526% for CLI and by 523% for claudication
(Fig 2, B).
Nationally, the decline in surgical interventions for
critical ischemia from 1998 to 2007 was highest among
octogenarians (from 317 to 240/100,000 capita) and in
patients aged 65 to 79 years (from 199 to 160/100,000
capita; Fig. 3, A). The rate of interventions increased for
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patients aged 65 to 79 years (33/capita increase) and
octogenarians (31/capita increase; Fig 3, B). This trend
was less notable for the treatment of other LE PAD (Fig 3,
C). We also observed a decline in rate for octogenarians and
for patients aged 65 to 75, and a stable rate for patients
aged 40 to 64 years. Interestingly, outpatient interventions
increased for CLI, claudication, and other diagnoses in all
age groups (Fig 3, D, E, and F).
The decline in the rate of treatment among elderly with
CLI and other PAD led to a slight decrease in the mean age
of surgical patients, from 70 years in 1998 to 69 in 2007.
Not only were more claudication and fewer critical
ischemia cases treated surgically during the study period,
Fig 1. A,National and (B)New York State trends in treatment of
patients with lower extremity arterial diseases are shown based on
Nationwide Inpatient Sample and New York State Health Depart-
ment’s Statewide Planning and Research Cooperative System
(SPARCS) data. National estimates are presented with the 95%
confidence limits. Amp, Major amputations; Endo, endovascular
revascularizations; LER, lower extremity revascularizations; Open,
open revascularizations.but we also confirmed a dramatic change in the type ofintervention. Although the proportion of open revascular-
izations declined from 65% to 32% for claudication (Fig 4,
A), from 41% to 27% for critical ischemia (Fig 4, B), and
from 51% to 31% for other PAD cases (Fig 3, C), the use of
endovascular revascularizations quadrupled for critical isch-
emia (from 8% to 32%) and doubled for claudication (from
26% to 61%) and other PAD cases (from 23% to 47%; Fig
4). Significantly, a parallel reduction occurred in major
amputations from 42% to 30% for CLI, from 18% to 14%
for other PAD diagnoses, and from 0.9% to 0.3% for
claudication. Interestingly, the reduction of major amputa-
tions for CLI was observed for both diabetic (by 27%) and
nondiabetic patients (by 32%).
Patients with CLI were twice as likely to have diabetes
and three times as likely to have renal diseases (Table II).
CAD and COPDwere more common among patients with
Fig 2. A,National inpatient and (B)New York State ambulatory
trend in treatment of patients with critical limb ischemia (CLI),
claudication (Claud), and other peripheral arterial disease diag-
noses (Other Diag). The 95% confidence limits for national esti-
mates are shown.claudication.
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rather than open revascularization, was the preferred treat-
ment for patients with CAD and renal diseases in 1998 as
well as in 2007. However, more diabetic patients had open
vs endovascular revascularization in 1998 (40.4% vs
38.2%). These ratios were reversed in 2007: 43.3% diabetic
patients had endovascular and 38.6% had open revascular-
ization. Diabetes was a comorbidity highly associated with
major amputations for the entire period: 62.4% in 1998 and
63.5% in 2007 (Table III). Overall, we observed an increas-
ing trend in hypertension, renal disease, CAD, hyperlipid-
emia, and chronic pulmonary comorbid conditions among
all patient groups.
Complication rates are depicted in Table IV. As ex-
pected, these were higher for open vs endovascular proce-
dures in both 1998 and 2007. A small proportion of
patients had multiple procedures during the same hospital-
izations: open with endo LER (5.2% in 1998 and 6.2% in
2007) or revascularization with major amputation (3.1% in
1998 and 2.6% in 2007 hospitalizations). Complication
rates were higher in patients with multiple interventions.
There was improvement in bleeding complications for all
procedures; cardiac complication rates dropped for major
amputations, endovascular, and open revascularizations;
and infection rates decreased for endovascular and major
Fig 3. National and ambulatory surgery trends in proc
ischemia, (B, E) claudication, and (C, F) other lower ex
C are national inpatient hospitalizations based on the Na
surgeries based on New York State data.amputation surgeries.Overall, hospital surgical mortality declined from 4.8%
to 2.6% (P  .0001; Fig 5). We observed reduction in
mortality from 6.9% to 5.3% for major amputation, from
3.9% to 2.7% for open revascularization, and from 2.4% to
1.1% for endovascular revascularizations. Although mortal-
ity for revascularization with major amputation was the
highest, it declined from 12.8% in 1998 to 8.2% in 2007
(Fig 5). Mortality after open and endovascular revascular-
izations performed during the same hospitalization also
declined from 4.0% to 2.7%.
We also observed an improvement in LOS. Overall
mean LOS was 9.5 days in 1998 and 7.6 days in 2007; for
survivors, LOS was 9.2 days (range, 8.7-9.5) and 7.6 days
(range, 7.2-7.9), respectively. Nearly 16% of patients were
discharged within 1 to 2 days in 1998 and 35% in 2007.
Approximately 50% of patients were hospitalized for 7
days in 1998 and 38% in 2007. The proportion of
medium stays also decreased, from 35% in 1998 to 27%
in 2007 (Fig 6).
DISCUSSION
Our analysis of national inpatient and outpatient state
data supports the trend toward increasing treatment of
PAD by endovascular intervention. We examined proce-
dural changes for the years 1998 through 2007 by indica-
l hospitalizations for patients with (A, D) critical limb
ty peripheral arterial diagnoses by age groups. A, B, and
ide Inpatient Sample data; D, E, and F are ambulatoryedura
tremi
tionwtion for intervention and major outcomes, specifically ana-
Open, open revascularizations.
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found that increased endovascular intervention was paral-
leled with a decline in open LE revascularizations andmajor
amputations. We also witnessed an improvement in major
outcomes after all procedures.
We previously published an article evaluating the effect
of evolution in treatments on limb loss. For 1998 through
2003, we found that amputations in the United States were
declining, even in high-risk patients, defined as those with
diabetes, CAD, renal insufficiency, and COPD; however,
mortality, at 6%, continued to be substantial.6 Our current
study, which examines trends until 2007, documented the
same continuing shift toward increasing endovascular in-
tervention and declining amputation rates. Other, primarily
European studies, observed a similar correlation between
endovascular procedures and amputation rates. Luther et
al,5 for example, found that a higher incidence of infrapop-
liteal surgical reconstruction correlated with a lower inci-
dence of amputations. Although the studies document
variable rates of LER since the mid-1990s, most confirm
our finding of a generalized decline in major amputation
rates during the past decade.3,5,8-10
Recently, Rowe et al10 published similar findings to our
own. They examined trends from 1996 to 2005 and re-
ported an increase in endovascular procedures and a de-
crease in the rates of major amputations for patients admit-
Table II. Comorbid conditions of patients with
claudication, critical limb ischemia, and other lower
extremity peripheral arterial diagnoses who had a vascular
intervention in 1998 and in 2007 based on Nationwide
Inpatient Sample database
Comorbidity by group 1998, % 2007, % P
Claudication
Diabetes 28.1 33.7 .0001
Hypertension 57.4 76.5 .0001
COPD 21.1 22.4 .164
Coronary artery disease 40.0 53.3 .0001
Renal 3.3 9.5 .0001
Cerebral 7.4 7.6 .7232
Lipids 10.7 16.1 .0001
Critical limb ischemia
Diabetes 58.9 58.1 .39
Hypertension 53.9 70.9 .0001
COPD 18.1 22.2 .0001
Coronary artery disease 33.3 39.2 .0001
Renal 16.1 31.7 .0001
Cerebral 9.6 7.7 .0001
Lipids 3.4 9.3 .0001
Other diagnosis
Diabetes 36.9 37.8 .29
Hypertension 49.4 70.7 .0001
COPD 19.6 24.1 .0001
Coronary artery disease 34.1 43.2 .0001
Renal 9.9 21.0 .0001
Cerebral 7.6 7.4 .68
Lipids 5.5 11.2 .0001
COPD, Chronic obstructive pulmonary disease.Fig 4. National trend in proportion of surgeries for treatment of
(A) lower extremity claudication, (B) critical ischemia, and (C)
other peripheral arterial diagnoses. The lines for amputation
(Amp) and amputation with lower extremity revascularizations
(LER) for claudication are not shown because the proportion of
these procedures is 1%. Endo, endovascular revascularizations;ted with acute PAD. Although the study also analyzed
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cluded more expansive data in several areas.
First, our study separately analyzed the data by indica-
tion for intervention and compared patients with and with-
out diabetes. We examined three distinct subgroups: clau-
dication, CLI, and patients with other PAD diagnoses. For
the period 1998 to 2007, open LER decreased not only for
patients with claudication (by 50%) but also critically isch-
emic patients (by 38%) who were at imminent risk of limb
loss. At the same time, endovascular revascularizations in-
creased for all patient groups, quadrupling for CLI and
Table III. Comorbid conditions of patients who had
endovascular or open revascularization, major
amputations, both major amputations and
revascularizations during the same hospitalization, or
both open and endovascular procedures during the same
hospitalization in 1998 and in 2007
Comorbidity by procedure type 1998, % 2007, % P
Endo revascularization
Diabetes 38.2 43.3 .0001
Hypertension 53.9 74.6 .0001
COPD 16.6 20.2 .0001
Coronary artery disease 39.4 49.2 .0001
Renal 12.5 22.6 .0001
Cerebral 8.9 7.9 .12
Lipids 7.9 11.8 .0001
Open revascularization
Diabetes 40.4 38.6 .08
Hypertension 54.8 72.9 .0001
COPD 21.4 26.9 .0001
Coronary artery disease 36.4 43.7 .0001
Renal 8.2 15.4 .0001
Cerebral 7.3 6.8 .20
Lipids 6.3 14.2 .0001
Major amputations
Diabetes 62.4 63.5 .20
Hypertension 48.1 65.3 .0001
COPD 15.0 20.5 .0001
Coronary artery disease 28.6 31.6 .002
Renal 18.2 36.7 .0001
Cerebral 10.7 7.9 .0001
Lipids 1.6 5.6 .0001
Major amputation 
revascularization
Diabetes 48.2 51.1 .20
Hypertension 49.7 64.6 .0001
COPD 22.4 23.8 .45
Coronary artery disease 26.1 31.9 .005
Renal 18.3 37.8 .0001
Cerebral 8.1 8.0 .97
Lipids 3.1 6.1 .0001
Open  endo revascularization
Diabetes 37.3 37.1 .89
Hypertension 53.6 71.8 .0001
COPD 24.2 30.3 .0001
Coronary artery disease 37.7 43.8 .0001
Renal 7.4 16.7 .0001
Cerebral 7.4 7.7 .65
Lipids 6.7 13.5 .0001
COPD, Chronic obstructive pulmonary disease; Endo, endovascular.doubling for claudication.Diabetic patients with CLI were separately reviewed;
the number of major amputations is declining even in this
high-risk cohort. Better treatments for diabetes and
wounds may be contributing to the improvement in limb
Table IV. Postoperative complications by procedure
type in 1998 and 2007: endovascular and open
revascularization, major amputations, both major
amputations and revascularizations during the same
hospitalization, or both open and endovascular
procedures during the same hospitalization
Procedure and complication 1998, % 2007, % P
Endo revascularization
Cardiac 1.6 0.8 .0001
Postoperative stroke 0.2 0.1 .04
Respiratory 0.8 0.7 .21
Bleeding 9.9 6.7 .0001
Infection 1.7 1.3 .02
Open revascularization
Cardiac 3.0 2.2 .0006
Postoperative stroke 0.4 0.3 .03
Respiratory 2.9 3.2 .20
Bleeding 14.3 10.8 .0001
Infection 3.4 3.8 .10
Major amputation
Cardiac 1.6 1.4 .42
Postoperative stroke 0.3 0.1 .05
Respiratory 2.6 2.2 .09
Bleeding 8.9 7.8 .09
Infection 3.7 4.6 .005
Major amputation 
revascularization
Cardiac 4.4 3.5 .19
Postoperative stroke 0.45 0.4 .78
Respiratory 6.5 6.2 .75
Bleeding 23.1 16.7 .0004
Infection 9.1 7.2 .11
Open  endo revascularization
Cardiac 3.2 2.1 .02
Postoperative stroke 0.1 0.4 .08
Respiratory 2.7 3.4 .17
Bleeding 16.3 13.6 .03
Infection 3.0 3.2 .83
Endo, Endovascular.
Fig 5. Mortality rates are shown for lower extremity vascular
procedures in 1998 (blue bars) and 2007 (red bars). Amp, Major
amputations; Endo, endovascular revascularizations; LER, lower ex-
tremity revascularizations; Open, open revascularizations. *P .05.salvage. In one 2007 study, nondiabetic CLI patients un-
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tion had better clinical success and a lower rate of amputa-
tion after 1 year than diabetic CLI patients who received
conservative, “best medical therapy” treatments. However,
repeated target extremity revascularization significantly im-
proved clinical success for both nondiabetic and diabetic
patients.11 A British study analyzing current revasculariza-
tion practices and outcomes for nondiabetic and diabetic
patients with CLI found similar results: an aggressive mul-
tidisciplinary approach yielded comparable limb salvage,
amputation-free survival, mortality, and major amputation
rates in both groups.12
Second, we included outpatient data, which accounts
for a significant portion of patients who had PAD-related
procedures. Endovascular therapies are being increasingly
performed as ambulatory procedures. The NY State data-
base, unlike the national surveys that include only hospital-
ized patients, allowed us to include ambulatory surgeries
and separately evaluate this growing subset of patients.
If the NY State data are any index of national trends, as
they do appear to be in our other comparative evaluations,
treatment has shifted substantially to an outpatient setting
for all diagnostic subgroups and all age groups. Total
inpatient interventions during this period declined about
10%, and although doubling for the claudicant subgroup,
outpatient treatment volume has had a rapid increase
(500% for CLI and claudication).
Third, we analyzed major outcomes; namely, LOS,
mortality, and complications. Overall, our analysis showed
an improvement in major outcomes. In parallel with the
move towards ambulatory care, there was a significant
decrease in LOS from 9.5 to 7.6 days and an increase in the
number of short hospitalizations (1 to 2 days) from 16% to
35%. The implementation of minimally invasive endovas-
cular procedures contributes to the reduction in LOS.
Henke13 confirmed our finding that the average hospital
LOS for amputation patients with acute limb ischemia was
Fig 6. Proportion of hospitalizations is shown for treatment of
lower extremity peripheral arterial diseases with short (1-2 days),
medium (3-6 days), and long (7 days) length of stay in 1998 and
2007 based on the Nationwide Inpatient Sample database. *P .05.approximately 10 days. A similar LOS was observed fordiabetic patients who underwent LE amputations.14 In
parallel with the rising number of endovascular LER and
the declining number of open LER and amputations ob-
served in our study, there has been a substantial decrease in
the LOS.
Mortality has declined from 4.2% to 2.7%. Also ob-
served was a decrease in major amputations for all diagnos-
tic categories, including the CLI patients (42% to 30%).
Cardiac complications, which have generally been the most
common and troubling, were significantly decreased in all
treatment groups, except those with combined open and
endovascular revascularizations. This, despite a significant
rise in the number of patients with baseline CAD and a
generally stable, if not increased, incidence of diabetes.
Numbers in nearly all medical comorbidity categories were
significantly higher, particularly for renal disease which has
almost doubled in frequency, reflecting a current patient
population at a substantially higher theoretic risk for poorer
outcome and increased morbidity and mortality.
One could speculate that the reduction in complication
rates is due to the selection of a patient population that is
less sick. Our study, however, found that the opposite is
true. In 2007, patients with LE PAD presented for treat-
ment with more comorbid conditions than did their 1998
counterparts.
Although the decline in amputation rates seems likely
due in large part to the increased use of endovascular
interventions, other variables are clearly operative, includ-
ing improved endovascular technology, better diabetes
management and foot care, and improving and more ubiq-
uitous application of medical therapies.15,16 For example,
vascular patients receiving perioperative statin therapy had
fewer complications after surgery than patients receiving a
placebo.17 Statin therapy also increased the improvement
of claudication symptoms and was associated with a shorter
hospital LOS for patients undergoing infrainguinal vascular
surgery.17,18
A limitation of this and similar studies is the reliance on
the selective data available in large health care administra-
tive data sets. The primary purpose of these data sets is to
credit reimbursement for hospital care delivered, and there-
fore, they lack the physiologic variables and anatomic char-
acteristics needed to produce a thorough analysis of treat-
ment groups.
In addition, neither NIS nor SPARCS include patient
identifiers, which prevented us from monitoring patients
longitudinally and inhibited our ability to distinguish be-
tween primary and secondary amputations or redo proce-
dures; the ICD9 codes did not allow us to distinguish
“laterality.” Therefore, one factor that may be expanding
apparent patient volume is an increase in frequency of
interventions in the same patient after an initial failure or
recurrence. Considering the often-limited durability of en-
dovascular procedures, future studies are needed to evalu-
ate primary and secondary interventions, readmissions, and
complications.
Recognizing the potential limitations of large survey
national data sets, we separately evaluated NY State inpa-
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sampling projections. Our analysis of NY State data yielded
trends similar to NIS data; however, the NY State data set is
not without its own limitations. We included all NY State
discharges in our analysis. This data set, therefore, may be
weighted towards the larger urban communities and may
not reflect the trend in smaller population communities.
Further studies are required to analyze geographic varia-
tions in the utilization of endovascular procedures in the
United States.
On the basis of our analysis of trends in the treatment of
LE PAD, we predict that the volume of endovascular
treatments will continue to increase and the volume of
open revascularization will decrease. Because of the safety
of the minimally invasive nature of endovascular proce-
dures, we expect these treatments will be performed more
regularly on an outpatient basis.
CONCLUSION
Although patients today, whether treated for claudica-
tion or CLI, have more comorbidities, the rates of ampu-
tation, the procedural morbidity and mortality, and the
LOS have all significantly decreased. Other variables, in-
cluding changes in medical management and wound care
are undoubtedly involved, but this appears due in large part
to the widespread and successful use of endo LER or to
earlier intervention, or both, driven by the safety of these
techniques.
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ategory
Procedure codes
ICD9 CPT
LER
Open 39.29, 38.08, 38.18,
38.38, 38.48,
38.88
35555, 35556, 35571, 35565
35587, 35658, 35688, 356
35538, 35638, 35540, 356
35558, 35637, 35638, 356
35884, 35871, 35681, 358
35879, 35881,35302, 3530
35305, 35306
Endo 39.50, 39.90 36245, 36246, 36247, 35248
35492, 35493, 35495, 354
35474, 35470, 37205, 372
37185, 37186, 37799
Major
Amp
84.13, 84.14, 84.15,
84.16, 84.17
27590, 27880, 27882, 27885
Amp, Amputation; CPT, Current Procedural Terminology; Endo, endovas
extremity revascularization.population selection
Diagnoses codes
ICD9
250.7, 440.2, 442.3, 443.9, 444.22, 996.74
, 35583, 35585,
23, 35637,
54, 35661,
39, 35883,
75, 35876,
3, 35304,
, 35491,
72, 35473,
06, 37184,
, 27596, 27888 250.7, 440.20, 440.22, 440.23, 440.24, 440.30,
440.31, 440.32, 444.22, 445.02, 447.1,
729.5, 730.06, 730.07, 730.16, 730.17,
785.4, 996.74, 997.62, 998.59
cular; ICD9, International Classification of Disease, Ninth Revision; LER, lower
